Consistent with this, L-NAME administration did not alter mesenteric artery expression of the enzyme responsible for production of nitric oxide Nos3, the endothelial dysfunction marker Vcam-1, or the receptors for vasoconstrictor endothelin-1, Ednra and Ednrb (Fig S7). The gene discussed is VCAM1; the disease is endothelial dysfunction.